Skip to content

Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical, sold RARE on Sep 3, 2026

Data as of Oct 16

▼ SELL$2.3K161 shares at $13.99Theodore Alan Huizenga SVP, Chief Accounting OfficerRARE Ultragenyx Pharmaceutical Inc.
Watch RARE
Traded
Sep 3, 2026
Disclosed
Sep 8, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical, sold RARE on Sep 3, 2026TRADEDDISCLOSED
RARESimilar stocks (XLV — its sector index fund), rebased to RARE's price on the disclosure day
RARE since disclosure
−2.3%
after the sale
Similar stocks (XLV) since disclosure
+5.7%
XLV — its sector index fund

Change in closing price from Sep 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on RARE →